Careerz Group, a leader in assessment-driven hiring, retention, and career development solutions, today announced it has acquired all assets of DreamJob Discovery from author and creator of the ...
"Our daughter didn’t die from bad luck. She died from a system that wasn’t built to save her." ...
Zacks Small Cap Research on MSN
CVKD acquires 12-LOX inhibitor for the treatment of heparin-induced thrombocytopenia (HIT)
By David Bautz, PhD NASDAQ:CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Acquires 12-LOX Inhibitor VLX-1005 for the Treatment of HIT In December 2025, Cadrenal Therapeutics, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results